Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

Oracle To Rally Around 40%? Here Are 10 Top Analyst Forecasts For Tuesday

Published 12/03/2024, 13:17
Updated 12/03/2024, 14:40
© Reuters.  Oracle To Rally Around 40%? Here Are 10 Top Analyst Forecasts For Tuesday

Benzinga - by Avi Kapoor, Benzinga Staff Writer.

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.

  • Oppenheimer cut the price target for ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) from $25 to $19. Oppenheimer analyst Jay Olson maintained a Perform rating. ACADIA Pharmaceuticals shares gained 2.9% to close at $24.13 on Monday. See how other analysts view this stock.
  • HSBC cut the price target for Asana, Inc. (NYSE: ASAN) from $18 to $16. HSBC analyst Stephen Bersey maintained a Reduce rating. Asana shares fell 1% to close at $18.79 on Monday. See how other analysts view this stock.
  • Wedbush boosted Micron Technology, Inc. (NASDAQ: MU) price target from $95 to $103. Wedbush analyst Matt Bryson maintained an Outperform rating. Micron shares fell 3.2% to close at $94.51 on Monday. See how other analysts view this stock.
  • Morgan Stanley cut the price target for NIKE, Inc. (NYSE: NKE) from $125 to $124. Morgan Stanley analyst Alex Straton maintained an Overweight rating. NIKE shares gained 1.9% to close at $101.08 on Monday. See how other analysts view this stock.
  • Wedbush increased SentinelOne, Inc. (NYSE: S) price target from $28 to $32. Wedbush analyst Taz Koujalgi maintained the stock with an Outperform rating. SentinelOne shares fell 1.8% to close at $26.97 on Monday. See how other analysts view this stock.
  • Baird raised the price target for Hyatt Hotels Corporation (NYSE: H) from $150 to $160. Baird analyst Michael Bellisario maintained a Neutral rating. Hyatt shares fell 1.6% to close at $154.17 on Monday. See how other analysts view this stock.
  • Mizuho increased Vaxcyte, Inc. (NASDAQ: PCVX) price target from $69 to $113. Mizuho analyst Salim Syed maintained a Buy rating. Vaxcyte shares fell 3.4% to close at $70.25 on Monday. See how other analysts view this stock.
  • Mizuho boosted Oracle Corporation (NYSE: ORCL) price target from $140 to $160. Mizuho analyst Siti Panigrahi maintained a Buy rating. Oracle shares rose 1.5% to close at $114.13 on Monday. See how other analysts view this stock.
  • B of A Securities increased EQT Corporation (NYSE: EQT) price target from $52 to $60. B of A Securities analyst Doug Leggate maintained a Buy rating. EQT shares fell 7.8% to close at $34.61 on Monday. See how other analysts view this stock.
  • JP Morgan raised Dollar General Corporation (NYSE: DG) price target from $120 to $158. JP Morgan analyst Matthew Boss upgraded the stock from Underweight to Neutral. Dollar General shares rose 1.3% to close at $159.33 on Monday. See how other analysts view this stock.
3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Check This Out: Over $1.7M Bet On Globalstar? Check Out These 4 Penny Stocks Insiders Are Aggressively Buying

Latest Ratings for ORCL

Mar 2022B of A SecuritiesMaintainsNeutral
Mar 2022BMO CapitalMaintainsMarket Perform
Mar 2022Piper SandlerDowngradesNeutralUnderweight

View the Latest Analyst Ratings

© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Read the original article on Benzinga

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.